October 4, 2022
LaTonya Hickson, M.D.: Seeking a cellular therapy for chronic kidney disease
Every year, more than 130,000 people in the U.S. are diagnosed with end-stage kidney disease, with most cases caused by diabetes. Newer therapies show promise to slow kidney failure rates, but none stop progression to end-stage kidney failure. The research goal of LaTonya Hickson, M.D., is to develop a cell-based therapy that slows — or […]
Tags: #diabetic kidney disease, #Dr. LaTonya Hickson, #end stage kidney disease, #Mayo Clinic Center for Regenerative Biotherapeutics, #mesenchymal stem cells, #stem cell research